TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Mid-Size Pharmaceutical – By Type
1.3.2 Europe Mid-Size Pharmaceutical – By Drug Development Type
1.3.3 Europe Mid-Size Pharmaceutical – By Formulation
1.3.4 Europe Mid-Size Pharmaceutical – By Therapy Area
1.3.5 Europe Mid-Size Pharmaceutical – By Country
2. Mid-Size Pharmaceutical– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Mid-Size Pharmaceutical – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Mid-Size Pharmaceutical Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Disorders
5.1.2 Increasing Product Approval and Launches
5.2 Market Restraints
5.2.1 Cutthroat Competition among Market Players
5.3 Market Opportunities
5.3.1 Rising Number of Healthcare Start-ups
5.4 Future Trends
5.4.1 Greater Focus on R&D
5.5 Impact Analysis
6. Mid-Size Pharmaceutical Market– Europe Analysis
6.1 Europe Mid-Size Pharmaceutical Market Revenue Forecast and Analysis
7. Europe Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type
7.1 Overview
7.2 Europe Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)
7.3 Prescription
7.3.1 Overview
7.3.2 Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Over-the-Counter (OTC)
7.4.1 Overview
7.4.2 Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Mid-Size Pharmaceutical Market Analysis – By Drug Development Type
8.1 Overview
8.2 Europe Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)
8.3 In-House
8.3.1 Overview
8.3.2 In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Outsource
8.4.1 Overview
8.4.2 Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Mid-Size Pharmaceutical Market – By Formulation
9.1 Overview
9.2 Europe Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)
9.3 Tablets and Capsules
9.3.1 Overview
9.3.2 Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Injectables
9.4.1 Overview
9.4.2 Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Sprays
9.5.1 Overview
9.5.2 Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Other Formulations
9.6.1 Overview
9.6.2 Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Mid-Size Pharmaceutical Market – By Therapy Class
10.1 Overview
10.2 Europe Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)
10.3 Cardiovascular Diseases
10.3.1 Overview
10.3.2 Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Pain Management
10.4.1 Overview
10.4.2 Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Diabetes
10.5.1 Overview
10.5.2 Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Cancer
10.6.1 Overview
10.6.2 Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Other Diseases
10.7.1 Overview
10.7.2 Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11. Europe Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis
11.1 Overview
11.1.1 Europe: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)
11.1.1.1 Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Germany: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.6 Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 France: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.6 France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 UK: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.6 UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4 Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Italy: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.4 Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.5 Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.6 Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5 Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 Spain: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.3 Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.4 Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.5 Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.6 Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6 Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3 Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.4 Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.5 Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.6 Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
12. Mid-Size Pharmaceutical Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 DAIICHI SANKYO COMPANY LIMITED
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Eisai Co., Ltd.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bausch Health Companies Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Regeneron Pharmaceuticals, Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sun Pharmaceutical Industries Ltd
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Alexion Pharmaceuticals, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mallinckrodt
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Endo Pharmaceuticals Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Les Laboratories Servier
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 UCB S.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES.
Table 1. Germany: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 5. France: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. France: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 7. France: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 11. UK: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 12. UK: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Italy: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 15. Italy: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 16. Italy: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 17. Spain: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Spain: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe: Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Europe: Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe: Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic Developments Done By Companies
Table 27. Glossary of Terms
